EyePoint Pharmaceuticals, Inc.
EYPT
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for intravitreal injection for the treā¦ read more
Healthcare
Biotechnology
20 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$16.47
Price-1.50%
-$0.25
1Y
Price
Market Cap
$1.130b
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-1112.6%
EBITDA Margin-1114.3%
Net Profit Margin-1001.2%
Free Cash Flow MarginRevenue
$51.898m
+19.9%
1y CAGR+8.4%
3y CAGR+9.3%
5y CAGREarnings
-$175.381m
-34.0%
1y CAGR-25.2%
3y CAGR-42.6%
5y CAGREPS
-$2.68
-15.5%
1y CAGR+0.8%
3y CAGR-12.0%
5y CAGRBook Value
$246.009m
$301.147m
Assets$55.138m
Liabilities$21.815m
DebtDebt to Assets
7.2%
-0.1x
Debt to EBITDAFree Cash Flow
-$151.309m
-16.1%
1y CAGR-2640.1%
3y CAGR-1988.5%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company